Alnylam Pharmaceuticals
ALNY
#485
Rank
HK$382.11 B
Marketcap
HK$2,892
Share price
-6.87%
Change (1 day)
43.83%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company